Position in NVAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,641,174
+$1,355,262 QoQ
Shares Held
1,448,108
-4.1% QoQ
Ownership
0.878%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,811,269,626 across 424 Biotechnology names. NVAX ranks #100 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,641,174 | 1,448,108 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $12,285,912 | 1,509,326 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $9,770,716 | 1,453,976 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $13,257,440 | 1,529,117 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $8,391,597 | 1,332,000 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $8,996,004 | 1,403,433 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,671,786 | 1,451,715 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,280,516 | 1,368,212 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $14,648,580 | 1,157,076 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $5,089,550 | 1,064,760 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,811,322 | 1,002,359 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,268,267 | 865,783 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,463,422 | 869,909 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,769,448 | 399,632 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,837,562 | 373,304 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,393,659 | 351,300 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,063,346 | 351,222 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $31,511,814 | 427,859 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $60,731,496 | 424,488 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $95,700,514 | 461,630 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $90,939,377 | 428,333 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $145,130,856 | 800,457 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $104,887,418 | 940,610 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $78,899,709 | 728,193 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $58,983,043 | 707,655 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $5,909,566 | 435,167 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||